Jim Olson: Bittersweet day as we held the final meeting of the National Cancer Institute (NCI) Moonshot Pediatric Immunotherapy Drug Development Network

Jim Olson, Principal Investigator at Seattle Children’s Research Institute, shared on LinkedIn:

“Bittersweet day as we held the final meeting of the National Cancer Institute (NCI) Moonshot Pediatric Immunotherapy Drug Development Network. Amazing consortium that is advancing multiple therapies into pediatric clinical trials. Our team presented work on bispecific antibodies that show excellent preclinical activity in models of a rare and aggressive form of leukemia (CBF:GLIS) that affects infants and toddlers.”

Source: Jim Olson/LinkedIn